Cargando…
Hypersensitivity to ticagrelor and low response to clopidogrel: a case report
Ticagrelor is widely used to treat acute coronary syndrome. Hypersensitivity reaction of ticagrelor is rarely recognized. A low response to clopidogrel, which occurs in up to 23% of patients, is an independent risk factor for stent thrombosis. Management of patients with a low response to clopidogre...
Autores principales: | Dai, Jing, Lyu, Shuzheng, Ge, Changjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia Pacific Association of Allergy, Asthma and Clinical Immunology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287072/ https://www.ncbi.nlm.nih.gov/pubmed/28154807 http://dx.doi.org/10.5415/apallergy.2017.7.1.51 |
Ejemplares similares
-
Aspirin/clopidogrel/ticagrelor: Diffuse ooze and bleeding: 2 case reports
Publicado: (2021) -
Ticagrelor as an Alternative for Clopidogrel-Associated Acute Arthritis
por: Bedy, Starr-Mar'ee C., et al.
Publicado: (2018) -
Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography
por: Olechowski, Bartosz, et al.
Publicado: (2016) -
Ticagrelor: Angioedema: case report
Publicado: (2021) -
Ticagrelor versus clopidogrel in the management of acute myocardial infarction
por: Volney, Candice, et al.
Publicado: (2019)